-
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
Janssen, J. B. E., Brahm, C. G., Driessen, C. M. L., Nuver, J., Labots, M., Kouwenhoven, M. C. M., Sanchez Aliaga, E., Enting, R. H., de Groot, J. C., Walenkamp, A. M. E., van Linde, M. E. & Verheul, H. M. W., 2024, In: Brain Communications. 6, 4, p. fcae241 fcae241.Research output: Contribution to journal › Article › Academic › peer-review
-
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
van Linde, M. E., Labots, M., Brahm, C. G., Hovinga, K. E., de Witt Hamer, P. C., Honeywell, R. J., de Goeij-de Haas, R., Henneman, A. A., Knol, J. C., Peters, G. J., Dekker, H., Piersma, S. R., Pham, T. V., Vandertop, W. P., Jiménez, C. R., Verheul, H. M. W. & van Linde, M. E., 15 Apr 2022, In: Clinical Cancer Research. 28, 8, p. 1595-1602 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo
Houweling, M., Abdul, U. K., Brahm, C., Lagerweij, T., Heukelom, S., Koken, P. W., Honeywell, R., Wedekind, L. E., Peters, G. J., Verheul, H., Sminia, P., Noske, D., Wurdinger, T. & Westerman, B. A., 2022, (E-pub ahead of print) In: Journal of Cancer Research and Clinical Oncology.Research output: Contribution to journal › Article › Academic › peer-review
- All publications